FSRH has advised that the use of the Mirena IUS can be extended up to 6 years for contraception.
An article by J. C. Stevenson & R. D. T. Farmer entitled 'HRT and breast cancer: a million women ride again' was published online on 11 March 2020 in the Climacteric.
Please see the latest update with regards to Evorel stock.
We are pleased to announce that Hugo Pedder has been co-opted onto the BMS Medical Advisory Council as Statistical advisor to the BMS.
The menopause transition can have a significant impact on many women, with more than 75 % experiencing menopausal symptoms, and a quarter describing severe symptoms.
The RCOG, BMS and FSRH have issued a press release regarding the HRT and contraceptive shortages.
Melanie Davies, chair of Fertility Preservation UK and BMS medical advisory council member raises concern over a new medical procedure that claims to allow women to delay the onset of the menopause by over a decade.
The British Menopause Society has issued this further update on the current availability of HRT products to provide guidance to BMS members and clinical practitioners in response to the ongoing HRT shortages.
A recent Lancet paper, updating the evidence on the association between hormone replacement therapy (HRT) and the risk of breast cancer made prominent headlines.
Several types of vaginal estrogen are now available and can be extremely helpful for treatment of the effects of menopausal estrogen deficiency on the vagina and bladder.